Itaconate is synthesized from aconitate via immune response gene 1 (IRG1), also known as aconitate decarboxylase (ACOD1), in tumor-associated myeloid cells and uptake of itaconate by CD8+ T cells has been shown to suppress their proliferation and cytolytic activity 49. This evidence concerns the gene CD8A and neoplasm.